Drugs for Skin Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 259)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Petrolatum |
Approved, Investigational |
Phase 4 |
|
8009-03-8 |
|
Synonyms:
Multi-hydrocarbon
Paraffinum album
Paraffinum flavum
Petrolatum
Petrolatum base
Petrolatum, white
Petrolatum,amber
|
Petrolatum,white
Petroleum jelly
Soft paraffin
White petrolatum
White, soft paraffin
Yellow soft paraffin
|
|
2 |
|
Etanercept |
Approved, Investigational |
Phase 4 |
|
185243-69-0 |
|
Synonyms:
BENEPALI
CD120B
ENBREL
Enbrel Sureclick
Etanercept
etanercept-szzs
etanercept-ykro
FC
GP2015
GP-2015
GP2015C
HD203
L04AB01
|
LBEC0101
P75
P80 TNF-ALPHA RECEPTOR
Recombinant human TNF
RHU TNFR
rhu TNFR:Fc
rhu-TNFR:Fc
TNF-R2
TNFR-Immunoadhesin
TUMOR NECROSIS FACTOR RECEPTOR 2
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B PRECURSOR
TUMOR NECROSIS FACTOR RECEPTOR TYPE II
|
|
3 |
|
Bacitracin |
Approved, Vet_approved |
Phase 4 |
|
1405-87-4 |
10909430 |
Synonyms:
A.L. labs brand OF bacitracin zinc salt
Ak tracin
Akorn brand OF bacitracin
Ak-tracin
ALBAC 50
Altracin
Baci im
Baci RX
BACIFERM 50
BACIGUENT
Baci-im
BACIIM
Baci-RX
Bacitin
Bacitracin
Bacitracin a
Bacitracin a2a
Bacitracin akorn brand
Bacitracin dioptic brand
BACITRACIN F, 1-(N-((2-(1-AMINO-2-METHYLBUTYL)-4,5-DIHYDRO-4-THIAZOLYL)CARBONYL)-L-LEUCINE)-
Bacitracin lee brand
Bacitracin mcneil brand
Bacitracin pharmascience brand
|
Bacitracin zinc
Bacitracin zinc complex
Bacitracin, zinc
Bacitracina
Bacitracine martinet
Ciba vision brand OF bacitracin
Dioptic brand OF bacitracin
E700
Lee brand OF bacitracin
Martinet, bacitracine
McNeil brand OF bacitracin
Ocu tracin
Ocumed brand OF bacitracin
Ocu-tracin
OcuTracin
Pharma tek brand OF bacitracin
Pharmascience brand OF bacitracin
Reed and carnrick brand OF bacitracin
Topitracin
Zeba RX
Zeba-RX
Zinc bacitracin
Zinc, bacitracin
|
|
4 |
|
Erythromycin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
114-07-8 |
12560 |
Synonyms:
(2R,4S,5R,8R,12R,14R)-11-[(3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLOXAN-2-YL]OXY-5-ETHYL-3,4,12-TRIHYDROXY-9-[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLOXAN-2-YL]OXY-2,4,8,10,12,14-HEXAMETHYL-6-OXACYCLOTETRADECANE-1,7-DIONE
(2R,4S,5R,8R,12R,14R)-11-[(3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYL-OXAN-2-YL]OXY-5-ETHYL-3,4,12-TRIHYDROXY-9-[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYL-OXAN-2-YL]OXY-2,4,8,10,12,14-HEXAMETHYL-6-OXACYCLOTETRADECANE-1,7-DIONE
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-14-ETHYL-7,12,13-TRIHYDROXY-4-(5-HYDROXY-4-METHOXY-4,6-DIMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-3,5,7,9,11,13-HEXAMETHYL-OXACYCLOTETRADECANE-2,10-DIONE
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
3''-O-Demethylerythromycin
6-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-14-ETHYL-7,12,13-TRIHYDROXY-4-(5-HYDROXY-4-METHOXY-4,6-DIMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-3,5,7,9,11,13-HEXAMETHYL-OXACYCLOTETRADECANE-2,10-DIONE(ERYTHROMYCIN)
A/T/S
Abboticin
Abomacetin
Ak-mycin
Akne-mycin
AKNEMYCIN PLUS
Aknin
BENZAMYCIN
Benzamycin Pak
BRISTAMYCIN
C, Erythromycin
C-SOLVE-2
Dotycin
Dumotrycin
E-BASE
E-GLADES
EM
EMGEL
EMU
E-MYCIN
E-Mycin®|EM-A|Erythrocin®|erythromycin-A
Eritrocina
Eritromicina
Ermycin
Erthromycin
ERYACNE 2
ERYACNE 4
Eryc
ERYC 125
ERYC SPRINKLES
Erycen
Erycette
Erycin
Erycinum
ERYDERM
Erygel
Erymax
ERYMAX SPRINKLE
ERYPAR
Ery-Sol
ERY-TAB
ERYTHRA-DERM
Erythro
ERYTHRO 200
ERYTHROCIN
Erythrocin stearate
Erythrogran
Erythroguent
Erythromast 36
Erythromid
ERYTHROMYCIN
Erythromycin a
|
Erythromycin B
Erythromycin C
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin lactate
Erythromycin lactobionate
Erythromycin oxime
Erythromycin phosphate
Erythromycin stearate
Erythromycine
ÉRYTHROMYCINE
Erythromycinum
ERYTHRO-STATIN
E-SOLVE 2
Ethril 250
ETS
GALLIMYCIN
Ilocaps
Ilosone
Ilotycin
Ilotycin Gluceptate
IndermRetcin
ISOTREXIN
J01FA01
KERYMAX
Kesso-Mycin
Lactate, erythromycin
Mephamycin
NSC-55929
OFTALMOLOSA CUSI ERITROMICINA
PAEDIATHROCIN
Pantomicina
Pce
PFIZER-E
Phosphate, erythromycin
Propiocine
RETCIN
ROBIMYCIN
ROMMIX 250 EC
ROMMIX 500 EC
R-P MYCIN
SANSAC
Serp-AFD
Staticin
STIEMYCIN
T Stat
Taimoxin-F
Theramycin Z
TILORYTH
Torlamicina
TStat
T-Stat
Wemid
WYAMYCIN
Wyamycin S
ZINERYT
|
|
5 |
|
Mineral oil |
Approved, Vet_approved |
Phase 4 |
|
8042-47-5 |
|
Synonyms:
Food Grade Mineral Oil
Heavy Liquid Petrolatum
Heavy mineral oil
Liquid Paraffin
Liquid Petrolatum
Mineral oil
Mineral Oil (high Viscosity)
|
Mineral Oil, Heavy
Paraffin Oil
Paraffin, Liquid
Paraffinum Liquidum
Petrolatum, Liquid
White Mineral Oil
|
|
6 |
|
Tacrolimus |
Approved, Investigational |
Phase 4 |
|
104987-11-3 |
6473866 445643 |
Synonyms:
(-)-FK 506
Anhydrous tacrolimus
Anhydrous, tacrolimus
Cilag brand OF tacrolimus
FK5
FK506
FK-506
FK506|fujimycin|Prograf®|Protopic®
FR-900506
FUJIMYCIN
Fujisawa brand OF tacrolimus
Janssen brand OF tacrolimus
|
K506
LCP-Tacro
Prograf
Prograft
PROTOPIC
Tacarolimus
TACROLIMUS
Tacrolimus anhydrous
tacrolimus hydrate
TACROLIMUS MONOHYDRATE
Tacrolimus, anhydrous
|
|
7 |
|
Azathioprine |
Approved |
Phase 4 |
|
446-86-6 |
2265 |
Synonyms:
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
Azamun
AZAMUNE
Azanin
AZAPRESS
Azasan
Azathioprin
AZATHIOPRINE
Azathioprine sodium
Azathioprine sodium salt
Azathioprine sulfate
Azathioprinum
Azatioprin
Azatioprina
|
Azothioprine
BERKAPRINE
BW-57-322
Ccucol
IMMUNOPRIN 50
Immuran
Imuran
IMURAN (TN)
Imurek
Imurel
KENTAPRINE
Muran
NSC-39084
OPRISINE 50
Sodium, azathioprine
|
|
8 |
|
Sirolimus |
Approved, Investigational |
Phase 4 |
|
53123-88-9 |
5284616 6436030 |
Synonyms:
(-)-Rapamycin
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
Antibiotic ay 22989
AY-22989
AY-22989|Fyarro® (sirolimus albumin-bound particles)|Rapamune®|rapamycin|WY-090217
L04AA10
NSC-226080
Perceiva
RAPA
Rapammune
|
Rapamune
Rapamycin
Rapamysin
RPM
Sirolimus
Sirolimús
Sirolimusum
SM-88 COMPONENT SIROLIMUS
WY-090217
|
|
9 |
|
Mycophenolic acid |
Approved, Investigational |
Phase 4 |
|
24280-93-1 |
446541 |
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
68618
Acid, mycophenolic
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
Cellcept
ERL080
ERL-080
ERL-080|Myfortic® (mycophenolate sodium)
Melbex
Micofenolico acido
Mofetil hydrochloride, mycophenolate
Mofetil, mycophenolate
|
Mycophenoic acid
Mycophenolate
Mycophenolate mofetil
Mycophenolate mofetil hydrochloride
Mycophenolate sodium
Mycophenolate, sodium
MYCOPHENOLIC ACID
Mycophenolic acid morpholinoethyl ester
Mycophenolsaeure
Mycophenolsäure
Myfortic
NSC-129185
RS-61443 [AS MOFETIL]
Sodium mycophenolate
|
|
10 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
22916-47-8 |
4189 |
Synonyms:
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
Brentan
CONOFITE
Dactarin
DERMAZOLE
DUMICOAT
Esteve brand OF miconazole
florid(nitrate)|Monistat®|R-14889
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
LORAMYC
MCZ
MICATIN
|
Miconasil nitrate
Miconazol
Miconazole
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazolum
Monistat
MONISTAT-3
MONISTAT-DERM
Nitrate, miconasil
Nitrate, miconazole
NSC-170986
Oravig
VUSION
|
|
11 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 4 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-Chloro-a,a-diphenylbenzyl)imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(O-Chloro-α,α-diphenylbenzyl)imidazole
1-(Α-(2-chlorophenyl)benzhydryl)imidazole
ABTRIM
ACTAVALL
Bay b 5097
BAY-5097
Bayer brand 1 OF clotrimazole
Bayer brand 2 OF clotrimazole
CANDIDEN
Canesten
Canesten 1-day cream combi-pak
Canesten 1-day therapy
Canesten 3-day therapy
Canesten 6-day therapy
CANESTEN AF
Canesten combi-pak 1-day therapy
Canesten combi-pak 3-day therapy
Canesten cream
CANESTEN CRM COMBI
CANESTEN INTERNAL
Canesten solution
CANESTEN VC
Canesten®|Lotrimin®
Canestine
Chlotrimazole
Clotrimaderm
Clotrimaderm cream
Clotrimazol
CLOTRIMAZOLE
Clotrimazole schering brand
Clotrimazolum
Desamix F
Empecid
FB b 5097
Fem care
FemCare
FUNGEDERM
GNF-PF-3499
Gyne lotrimin
Gyne-lotrimin
Gyne-lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-lotrimin combination pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
|
Gynix
Kanesten
Klotrimazole
Lopac-C-6019
Lotrimax
Lotrimin
LOTRIMIN (TN)
Lotrimin af
Lotrimin af cream
Lotrimin af jock-itch cream
Lotrimin af lotion
Lotrimin af solution
Lotrimin cream
Lotrimin lotion
Lotrimin solution
Lotrisone
MASNODERM
mono-Baycuten
Monobaycuten
Mycelax
Mycelex
MYCELEX (TN)
Mycelex 7
Mycelex cream
Mycelex g
Mycelex otc
Mycelex solution
Mycelex troches
Mycelex twin pack
Mycelex: mycosporinrimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-g
MYCIL GOLD
Myclo cream
Myclo solution
Myclo spray solution
Myclo-gyne
Mycosporin
Mykosporin
Neo-zol cream
NSC-257473
Otomax
Pedisafe
Prestwick_120
PRIVACOM
Rimazole
Schering brand OF clotrimazole
Tibatin
Trimysten
Trivagizole 3
Veltrim
|
|
12 |
|
Acetylcholine |
Approved, Investigational |
Phase 4 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
13 |
|
Dermatologic Agents |
|
Phase 4 |
|
|
|
14 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
15 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
16 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
17 |
|
Erythromycin stearate |
|
Phase 4 |
|
|
|
18 |
|
Erythromycin Ethylsuccinate |
|
Phase 4 |
|
|
|
19 |
|
Erythromycin Estolate |
|
Phase 4 |
|
|
|
20 |
|
Polymyxins |
|
Phase 4 |
|
|
|
21 |
|
Lubricant Eye Drops |
|
Phase 4 |
|
|
|
22 |
|
Calcineurin Inhibitors |
|
Phase 4 |
|
|
|
23 |
|
Cyclosporins |
|
Phase 4 |
|
|
|
24 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
25 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
26 |
|
Antifungal Agents |
|
Phase 4 |
|
|
|
27 |
|
Antimetabolites |
|
Phase 4 |
|
|
|
28 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
29 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
30 |
|
Agglutinins |
|
Phase 4 |
|
|
|
31 |
|
abobotulinumtoxinA |
|
Phase 4 |
|
|
|
Synonyms:
ABOBOTULINUMTOXINA
BONT/A
BONTOXILYSIN A
BOTOX
BOTULINUM TOXIN TYPE A
|
BOTULINUM TOXINS, TYPE A
BOTULOTOXIN A
BTX-A
ONABOTULINUMTOXINA
|
|
32 |
|
Botulinum Toxins, Type A |
|
Phase 4 |
|
|
|
33 |
|
Botulinum Toxins |
|
Phase 4 |
|
|
|
34 |
|
Hemagglutinins |
|
Phase 4 |
|
|
|
35 |
|
Cholinergic Agents |
|
Phase 4 |
|
|
|
36 |
|
Everolimus |
Approved |
Phase 3 |
|
159351-69-6 |
70789204 6442177 |
Synonyms:
001, RAD
40-O-(2-Hydroxyethyl)-rapamycin
42-O-(2-HYDROXYETHYL)RAPAMYCIN
Afinitor
AFINITOR DISPERZ
Afinitor®|Certican®|RAD-001|RAD001|rapamycin, 42-O-(2-hydroxyethyl)-|Zortress®
Certican
EVEROLIMUS
évérolimus
RAD 001
|
RAD 666
RAD, SDZ
RAD001
RAD-001
RAD-666
SDZ RAD
SDZ-RAD
VOTUBIA
ZORTRESS
|
|
37 |
|
Aminolevulinic acid |
Approved |
Phase 3 |
|
106-60-5 |
137 |
Synonyms:
5 Aminolaevulinate
5 Aminolevulinate
5-ALA
5-Amino-4-oxopentanoate
5-Amino-4-oxo-pentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxo-pentanoic acid
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Amino-levulinate
5-Aminolevulinic acid
5-Amino-levulinic acid
Acid hydrochloride, aminolevulinic
Acid, aminolevulinic
Acid, Delta-aminolevulinic
|
ácido 5-aminolevulínico
Aladerm
Aminolevulinate
Aminolevulinic acid
Amino-levulinic acid
Aminolevulinic acid hydrochloride
Bertek brand OF aminolevulinic acid hydrochloride
dALA
Delta Aminolevulinic acid
delta-ALA
delta-Aminolevulinate
delta-Aminolevulinic acid
Hydrochloride, aminolevulinic acid
Kerastick
Levulan
δ-ALA
Δ-aminolevulinate
δ-aminolevulinic acid
|
|
38 |
|
Eflornithine |
Approved, Withdrawn |
Phase 3 |
|
70052-12-9 |
3009 |
Synonyms:
(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid
2-(difluoromethyl)ornithine
2-(difluoromethyl)ornithine (DMFO)|difluoromethylornithine|Ornidyl®|Vaniqa®
a-(Difluoromethyl)-DL-ornithine
a-Difluoromethylornithine
alpha Difluoromethyl ornithine
alpha Difluoromethylornithine
alpha-(Difluoromethyl)-DL-ornithine
alpha-Difluoromethyl ornithine
alpha-Difluoromethylornithine
DFMO
Difluoromethylornithine
DL alpha Difluoromethylornithine
DL-alpha-Difluoromethylornithine
|
Eflornithine
Eflornithine hydrochloride
Eflornithine monohydrochloride, monohydrate
Hydrochloride, eflornithine
MDL 71,782 a
MDL71,782 a
MDL-71,782 a
Monohydrochloride, monohydrate eflornithine
Ornidyl
Ornithine, alpha-difluoromethyl
Vaniqa
Women first brand OF eflornithine hydrochloride
Α-(difluoromethyl)-DL-ornithine
Α-difluoromethylornithine
|
|
39 |
|
Acetaminophen |
Approved |
Phase 3 |
|
103-90-2 |
1983 |
Synonyms:
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4'-Hydroxyacetanilide
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
A.F. anacin
ABDINE
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-tap
Acenol
Acephen
Acertol
Aceta elixir
Aceta tablets
Acetaco
Acetagesic
Acetalgin
Acetamidophenol
Acetaminofen
ACETAMINOFÉN
ACETAMINOPHEN
Acetaminophen uniserts
acetaminophen|Panadol®|Tylenol®
Acetaminophene
ACÉTAMINOPHÈNE
Acetamol
Acetofen
Acetominophen
Actamin
Actamin extra
Actamin super
Actifed plus
Actimol
Actimol chewable tablets
Actimol children's suspension
Actimol infants' suspension
Actimol junior strength caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
alpha-Per
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen max
Anacin
Anacin 3
Anacin3
Anacin-3
Anacin-3 extra strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
ANGIERS
Anhiba
Anoquan
Anti-algos
Antidol
Apacet
Apacet capsules
Apacet elixir
Apacet extra strength caplets
Apacet extra strength tablets
Apacet regular strength tablets
Apadon
Apamid
Apamide
APAP
a-Per
Apitrelal
Apo-acetaminophen
Arfen
Asetam
Asomal
Aspac
Aspirin free anacin maximum strength caplets
Aspirin free anacin maximum strength gel caplets
Aspirin free anacin maximum strength tablets
Aspirin-free anacin
Aspirin-free excedrin caplets
Asplin
Atasol
Atasol caplets
Atasol drops
Atasol forte caplets
Atasol forte tablets
Atasol oral solution
Atasol tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap HC
Banesin
Bayer Select
Bayer select allergy-sinus
Bayer select head cold
Bayer select headache pain
Bayer select maximum strength headache pain relief formula
Bayer select menstrual multi-symptom
Bayer select sinus pain relief
Benmyo
Ben-u-ron
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
Cadafen
Calapol
Calmanticold
Calpol
CALPOL SIX PLUS
CALPOL SIX PLUS FASTMELTS
Capital with codeine
Captin
Causalon
Cefalex
Cetadol
CHILD LEMSIP
Children'S acetaminophen elixir drops
Children'S acetaminophen oral solution
Children'S tylenol chewable
Claradol codeine
Clixodyne
Codabrol
COD-Acamol forte
Codalgin
Codapane
Codicet
Codisal
Codisal forte
Codoliprane
Codral pain relief
Cofamol
CO-Gesic
Conacetol
Contac cough & sore throat formula
Contra-schmerz p
Coricidin
Coricidin D
Coricidin sinus
Cosutone
Croix blanche
CUPANOL
Cuponol
Curadon
Curpol
Custodial
DAFALGAN
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril extra-strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
DHC Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
DISPROL INFANT
DISPROL JNR
DISPROL PAED
Dolcor
Dolefin
Dolegrippin
Dolene ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol forte
Dolorstop
Dolotec
Dolprone
Dol-stop
Dorocoff
Dresan
Dristan cold no drowsiness
Dristancito
Drixoral Plus
Dularin
Duracetamol
Duradyne DHC
Durapan
Dymadon
Dymadon co
Dymadon forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-plus
Eu-med
Excedrin
Excedrin caplets
Excedrin extra strength caplets
Excipain
Exdol
Exdol strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-gesic
Febrolin
Femcet
Fendon
FENNINGS
Fensum
Fepanil
Feverall
Feverall junior strength
Feverall sprinkle caps junior strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon p
Freka-cetamol
GALPAMOL
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap children's elixir
Genapap children's tablets
Genapap extra strength caplets
Genapap extra strength tablets
Genapap regular strength tablets
Genebs
Genebs extra strength caplets
Genebs regular strength tablets
Genebs X-tra
Geralgine-p
Gripin bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hycomine compound
Hydrocet
Hydroxyacetanilide
Hy-phen
Ildamol
Inalgex
Infadrops
Infants' feverall
Influbene N
Injectapap
Intensin
Janupap
Junior disprol
JUNIOR PARAPAED
Kataprin
Kinder finimal
Korum
Kratofin simplex
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liquagesic
Liquigesic co
Liquiprin
Liquiprin children's elixir
Liquiprin infants" drops
Lonarid
Lonarid mono
Lorcet-HD
Lortab
Lupocet
Lyteca
Lyteca syrup
Magnidol
Malex N
Malgis
Malidens
MANDANOL
Maxadol
Medigesic plus
MEDINOL
MEDINOL FOR CHILDREN
MEDINOL OVER 6
Medinol paediatric
MEDINOL UNDER 6
MEDISED PLAIN
Medocodene
Melabon infantil
Mexalen
Midol maximum strength
Midol PM night time formula
Midol regular strength
Midol teen formula
Migraleve yellow
Minafen
Minoset
MIRADOL
Miralgin
Momentum
|
mono Praecimed
Multin
N-(4-Hydroxyphenyl)acetamide
N-(4-Hydroxyphenyl)acetanilide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
Naldegesic
NAPA
Napafen
Napap
Naprinol
Nealgyl
Nebs
NeoCitran
Neodol
Neodolito
Neo-fepramol
Neopap
Neotrend
Neuridon
New cortal for children
NilnOcen
Nina
Nobedon
Nodolex
NO-Febril
Noral
Norcet
Norco
NSC-109028
NSC-3991
O-Acetaminophenol
OFIRMEV
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/apap 500
Oxycodone 5/apap 500
p-(Acetylamino)phenol
Paceco
Pacemo
Pacemol
Pacet
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine co
Panadiene
PANADO
Panado-co
Panado-co caplets
Panadol
PANADOL ACTIFAST
PANADOL ACTIFAST SOLB
PANADOL ADVAN
Panadol extra strength
PANADOL JNR
Panadol junior strength caplets
Panadol maximum strength caplets
Panadol maximum strength tablets
PANADOL OA
Panaleve
PANALEVE 6 PLUS
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-deine #3
Papa-deine #4
Paracemol
Paracenol
Paracet
Paracetamol
PARACÉTAMOL
Paracetamol al
Paracetamol antipanin p
Paracetamol basics
Paracetamol BC
Paracetamol DC
Paracetamol dr. schmidgall
Paracetamol fecofar
Paracetamol genericon
Paracetamol hanseler
Paracetamol harkley
Paracetamol heumann
Paracetamol hexal
Paracetamol italfarmaco
Paracetamol nycomed
Paracetamol PB
Paracetamol raffo
Paracetamol ratiopharm
Paracetamol rosch
Paracetamol saar
Paracetamol smithkline beecham
Paracetamol stada
Paracetamol von CT
Paracetamol winthrop
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
PARAMIN
Paramol
Paramolan
Paranox
PARAPAED JNR
PARAPAED SIX PLUS
Parapan
Parasedol
Parasin
Paraspen
Para-suppo
Para-tabs
PARAVICT
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
PCM Paracetamol lichtenstein
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-demi
Percogesic with codeine
Perdolan mono
PERFALGAN
Pe-tam
Phenaphen
Phenaphen caplets
Phenaphen w/codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin forte
P-HYDROXY-ACETANILID
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
Pinex
Piramin
Pirinasol
PLACIDEX
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet world
Redutemp
Reliv
Remedol
Rhinex D-lay tablets
RIMADOL
Rivalgyl
Robigesic
Robitussin night relief
Rockamol plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sinedol
Sine-OFF sinus medicine caplets
Sinmol
Sinubid
SK-Apap
Snaplets-FR
Spalt fur die nacht
Spalt N
ST Joseph aspirin-free
ST Joseph aspirin-free for children
St. joseph cold tablets for children
St. joseph fever reducer
Stanback
Stopain
Sudafed severe cold formula
Sudafed sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-m
Synalgos-DC-a
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol extra strength caplets
Tapanol extra strength tablets
Tapar
Tavist allergy/sinus/headache
Tazamol
Temlo
Tempanal
Tempra
Tempra caplets
Tempra chewable tablets
Tempra d.s
Tempra drops
Tempra syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
TIXYMOL
Tizide
Tocris-1706
Toximer p
Tralgon
TRAMIL 500
Treupel mon
Treupel N
Treuphadol
Triad
Triaminic sore throat formula
Triaprin
Tricoton
Tussapap
Tycolet
TYL
Tylenol
Tylenol allergy sinus
Tylenol arthritis extended relief
Tylenol caplets
Tylenol children's chewable tablets
Tylenol children's elixir
Tylenol children's suspension liquid
Tylenol drops
Tylenol elixir
Tylenol extra strength adult liquid pain reliever
Tylenol extra strength caplets
Tylenol extra strength gelcaps
Tylenol extra strength tablets
Tylenol gelcaps
Tylenol infants drops
Tylenol infants" suspension drops
Tylenol junior strength caplets
Tylenol junior strength chewable tablets
Tylenol regular strength caplets
Tylenol regular strength tablets
Tylenol tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor richet
Vicodin
Vicodin es
Vicodin HP
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
|
|
40 |
|
Carboplatin |
Approved |
Phase 3 |
|
41575-94-4 |
10339178 38904 |
Synonyms:
Blastocarb
Carboplat
CARBOPLATIN
Carboplatine
Carboplatino
Carbosin
Carbotec
Cbdca
CIS-(1,1-CYCLOBUTANEDICARBOXYLATO)DIAMMINEPLATINUM(II)
CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM
CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II)
|
Ercar
JM 8
JM8
JM-8
Nealorin
Neocarbo
NSC-201345
NSC-241240
PARAPLATIN
Paraplatin-AQ
Ribocarbo
|
|
41 |
|
Vinblastine |
Approved |
Phase 3 |
|
865-21-4 |
241903 13342 |
Synonyms:
(2a,2'b,3b,4a,5b)-VINCALEUKOBLASTINE
(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
(2Α,2'β,3β,4α,5β)-vincaleukoblastine
[3H]-VINBLASTINE
29060-LE|Velban®|Velbe®|vincaleucoblastin|vincaleukoblastine
Cell pharm brand OF vinblastine sulfate
Cellblastin
EG labo brand OF vinblastine sulfate
Faulding brand OF vinblastine sulfate
Gastrozepin brand OF vinblastine sulfate
Gry brand OF vinblastine sulfate
Hexal brand OF vinblastine sulfate
Lemblastine
Lemery brand OF vinblastine sulfate
Lilly brand OF vinblastine sulfate
Nincaluicolflastine
NSC-47842
Rozevin
|
Sulfate, vinblastine
Velban
Velbe
Vinblastin
Vinblastin hexal
Vinblastina
Vinblastina [Dcit]
Vinblastina lilly
Vinblastine
Vinblastine sulfate
Vinblastinsulfat-gry
Vinblastinum
Vinblastinum [INN-Latin]
Vincaleucoblastin
Vincaleucoblastine
Vincaleukoblastine
Vincoblastine
VLB
|
|
42 |
|
Dacarbazine |
Approved, Investigational |
Phase 3 |
|
4342-03-4 |
2942 5351166 |
Synonyms:
(E)-DACARBAZINE
4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide
4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide
4-(Dimethyltriazeno)imidazole-5-carboxamide
5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide
5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide
5-(Dimethyltriazeno)imidazole-4-carboxamide
Biocarbazine
Biocarbazine R
Carboxamide, dimethyl imidazole
Dacarbazin
Dacarbazina
Dacarbazine
Dacarbazino [INN-Spanish]
Dacarbazinum
Dacarbazinum [INN-Latin]
Decarbazine
Deticene
DIC
Dimethyl imidazole carboxamide
|
Dimethyl triazeno imidazole carboxamide
Di-me-triazenoimidazolecarboxamide
DTCI
DTIC
DTIC dome
Dtic-dome
DTICDome
DTIC-DOME (TN)
DTIE
HSDB 3219
ICDMT
ICDT
Imidazole carboxamide
Imidazole carboxamide, dimethyl
IMIDAZOLE-4-CARBOXAMIDE, 5-(3,3-DIMETHYL-1-TRIAZENO)-
NCI C04717
NCI-C04717
NSC 45388
NSC-45388
|
|
43 |
|
Ornithine |
Approved, Nutraceutical |
Phase 3 |
|
3184-13-2, 70-26-8 |
6262 |
Synonyms:
(+)-S-ORNITHINE
(2S)-2,5-DIAMINOPENTANOIC ACID
(S)-2,5-DIAMINOPENTANOATE
(S)-2,5-DIAMINOPENTANOIC ACID
(S)-2,5-Diaminovalerate
(S)-2,5-DIAMINOVALERIC ACID
(S)-A,D-DIAMINOVALERATE
(S)-A,D-DIAMINOVALERIC ACID
(S)-a,delta-Diaminovalerate
(S)-a,delta-Diaminovaleric acid
(S)-a,Δ-diaminovalerate
(S)-a,Δ-diaminovaleric acid
(S)-alpha,delta-Diaminovalerate
(S)-ALPHA,DELTA-DIAMINOVALERIC ACID
(S)-ORNITHINE
(S)-Α,δ-diaminovalerate
(S)-Α,Δ-DIAMINOVALERIC ACID
2,5 Diaminopentanoic acid
2,5-Diaminopentanoic acid
5-AMINO-L-NORVALINE
|
L-(-)-ORNITHINE
levo-ornithine
L-Ornithine
ORNITHINE
Ornithine dihydrochloride, (L)-isomer
Ornithine hydrochloride, (D)-isomer
Ornithine hydrochloride, (DL)-isomer
Ornithine hydrochloride, (L)-isomer
Ornithine monoacetate, (L)-isomer
Ornithine monohydrobromide, (L)-isomer
Ornithine monohydrochloride, (D)-isomer
Ornithine monohydrochloride, (DL)-isomer
Ornithine phosphate (1:1), (L)-isomer
Ornithine sulfate (1:1), (L)-isomer
Ornithine, (D)-isomer
Ornithine, (DL)-isomer
Ornithine, (L)-isomer
Ornithinum
Ornitina
|
|
44 |
|
Linrodostat |
Investigational |
Phase 3 |
|
1923833-60-6 |
121328278 |
Synonyms:
BMS-986205
BMS-986205|BMS986205|Compound 2 [PMID: 29531094]|Example 19 [US20160137652A1]
|
|
|
45 |
|
Radiation-Protective Agents |
|
Phase 2, Phase 3 |
|
|
|
46 |
|
Sunscreening Agents |
|
Phase 2, Phase 3 |
|
|
|
47 |
|
Protective Agents |
|
Phase 2, Phase 3 |
|
|
|
48 |
|
Photosensitizing Agents |
|
Phase 3 |
|
|
|
49 |
|
Antiprotozoal Agents |
|
Phase 3 |
|
|
|
50 |
|
Antiparasitic Agents |
|
Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 385)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients |
Completed |
NCT00492895 |
Phase 4 |
Discontinuation of Azathioprin |
2 |
Can We Miss Pigmented Lesions in Psoriasis Patients? |
Completed |
NCT01053819 |
Phase 4 |
etanercept |
3 |
The Role of Topical Antibiotic Prophylaxis in Eyelid Surgery |
Completed |
NCT03199911 |
Phase 4 |
Topical Antibiotic Product;Topical Non-Antibiotic Ointment |
4 |
A Randomized, Open-Label Study to Compare the Rate of New Non-Melanoma Skin Cancer in Maintenance Renal Allograft Recipients Converted to a Sirolimus-based Regimen Versus Continuation of a Calcineurin Inhibitor-based Regimen |
Completed |
NCT00129961 |
Phase 4 |
sirolimus;cyclosporine or tacrolimus |
5 |
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol |
Terminated |
NCT00866684 |
Phase 4 |
Sirolimus;Azathioprine;Mycophenolate;Ciclosporin;Tacrolimus |
6 |
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol |
Terminated |
NCT01797315 |
Phase 4 |
Sirolimus |
7 |
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy of AbobotulinumtoxinA (BTX-A) in Improving Forehead Wounds After Mohs Micrographic Surgery and Reconstruction for Skin Cancer |
Terminated |
NCT01459666 |
Phase 4 |
Dysport (abobotulinumtoxinA);Bacteriostatic 0.9% Sodium Chloride (vehicle) |
8 |
CERTICOEUR a Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. An Open Labelled Randomized Everolimus vs Calcineurin Inhibitors Multicenter Trial |
Unknown status |
NCT00799188 |
Phase 3 |
Everolimus |
9 |
A Phase 3, Randomized, Double-blind Study of BMS-986205 Combined With Nivolumab Versus Nivolumab in Participants With Metastatic or Unresectable Melanoma That is Previously Untreated |
Completed |
NCT03329846 |
Phase 3 |
BMS-986205;Placebo |
10 |
Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients - Multicentric Randomized, Open-label Study of Rapamycin vs Calcineurin Inhibitors |
Completed |
NCT00133887 |
Phase 3 |
rapamycin;ciclosporine;tacrolimus |
11 |
A Randomized Controlled Trial of Excisional Surgery Versus Imiquimod 5% Cream for Nodular and Superficial Basal Cell Carcinoma |
Completed |
NCT00066872 |
Phase 3 |
imiquimod |
12 |
Chemoprevention of Skin Cancers With DFMO: A Controlled, Randomized Clinical Trial |
Completed |
NCT00005884 |
Phase 3 |
eflornithine |
13 |
Impact of Preoperative Acetaminophen and Carbohydrate Loading to on Pain and Functional Status in Patients Undergoing Mohs Micrographic Surgery for Non-melanoma Skin Cancers |
Completed |
NCT03131713 |
Phase 3 |
Acetaminophen |
14 |
A Randomized Controlled Trial Of CHARTWEL (a Continuous Hyperfractionated Accelerated Radiotherapy Schedule) Versus Conventional Radiotherapy In Post-Operative Head And Neck Cancer Patients |
Completed |
NCT00021125 |
Phase 3 |
|
15 |
Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy in High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck |
Completed |
NCT00193895 |
Phase 3 |
Carboplatin |
16 |
Prospective Study To Determine Whether Tissue Scoring Results In Noticeable Marks Following Mohs Micrographic Surgery |
Completed |
NCT00367042 |
Phase 2, Phase 3 |
|
17 |
Adjuvant Therapy for Melanoma Patients With Regional Lymph Node Metastases With Interferon Alfa-2B vs. Biochemotherapy Using Cisplatin + Vinblastine + DTIC + Interferon Plus IL-2 |
Completed |
NCT00002882 |
Phase 3 |
Cisplatin;Dacarbazine;Vinblastine |
18 |
A Randomized Control Trial of Sun Protection Interventions for Operating Engineers |
Completed |
NCT01804595 |
Phase 2, Phase 3 |
|
19 |
Sun Safe Partners Online: Pilot Randomized Controlled Clinical Trial |
Completed |
NCT04549675 |
Phase 3 |
|
20 |
A Multicentre, Randomised Study of Photodynamic Therapy(PDT) With Metvix® 160 mg/g Cream in Immuno-compromised Patients With Non-melanoma Skin Cancer |
Completed |
NCT00472459 |
Phase 3 |
|
21 |
A Personalized Approach to Skin Cancer Prevention Among Adolescents |
Recruiting |
NCT04341064 |
Phase 3 |
|
22 |
Risk Information and Skin-Cancer Education and Undergraduate Prevention Trial |
Not yet recruiting |
NCT05634252 |
Phase 3 |
|
23 |
Investigation of the Effectiveness of Non-Coherent Blue Light in Intralesional Photodynamic of Basal Cell Carcinoma |
Unknown status |
NCT00747903 |
Phase 2 |
aminolevulinic acid hydrochloride |
24 |
A Phase I/II Pilot Study of Bioimmunotherapy With IRESSA (Gefitinib) and Pegylated Interferon Alpha-2a for Patients With Unresectable/Metastatic Squamous Cell Carcinoma of the Skin |
Unknown status |
NCT00423397 |
Phase 1, Phase 2 |
gefitinib |
25 |
Skin Cancer Prophylaxis by Low-Fat Dietary Intervention |
Unknown status |
NCT00003097 |
Phase 2 |
|
26 |
Transient Infrared Imaging for Early Detection of Skin Cancer |
Unknown status |
NCT02154451 |
Phase 1, Phase 2 |
|
27 |
A Phase 2 Study of SBRT for Squamous Cell Carcinoma of the Head and Neck |
Unknown status |
NCT04435938 |
Phase 2 |
|
28 |
Investigation of a Behavioral Substitute for Sunbathing |
Completed |
NCT00403377 |
Phase 1, Phase 2 |
|
29 |
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Evaluating the Efficacy of ABT-888 in Combination With Temozolomide Versus Temozolomide Alone in Subjects With Metastatic Melanoma |
Completed |
NCT00804908 |
Phase 2 |
temozolomide;ABT-888 |
30 |
Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis (Liposomal Cisplatin Formulation) in Patients With Advanced or Refractory Tumours |
Completed |
NCT01861496 |
Phase 1, Phase 2 |
LiPlaCis |
31 |
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes |
Completed |
NCT00509288 |
Phase 2 |
Cyclophosphamide;Fludarabine |
32 |
Phase 1/2 Study of ADI-SS PEG 20,000mw in Patients With Advanced Melanoma |
Completed |
NCT00520299 |
Phase 1, Phase 2 |
ADI PEG 20 |
33 |
A Phase II Study of Radiation Therapy and Vismodegib, for the Treatment of Locally Advanced Basal Cell Carcinoma of the Head and Neck |
Completed |
NCT01835626 |
Phase 2 |
Vismodegib |
34 |
Phase II Study in Patients With Metastatic Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of gp100 Reactive Peripheral Blood Lymphocytes (PBL) and High or Low Dose Aldesleukin |
Completed |
NCT00665470 |
Phase 2 |
Aldesleukin |
35 |
Study of Talabostat and Cisplatin in Advanced Melanoma |
Completed |
NCT00083252 |
Phase 2 |
talabostat (PT-100) tablets;cisplatin |
36 |
Study of Talabostat in Advanced Melanoma |
Completed |
NCT00083239 |
Phase 2 |
talabostat (PT-100) tablets |
37 |
A Phase II Study of ZD1839 (Iressa), Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor, in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Skin |
Completed |
NCT00054691 |
Phase 2 |
Iressa |
38 |
Cutaneous Absorption and Intralesional Penetration of Topical Amino-Levulinic Acid in Basal Cell Carcinoma and Squamous Cell Carcinoma as Measured by In Situ Fluorescence and Intensified Video Fluorescence Microscopy |
Completed |
NCT00002963 |
Phase 2 |
aminolevulinic acid hydrochloride |
39 |
Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients With Basal Cell Carcinomas |
Completed |
NCT01108094 |
Phase 2 |
Itraconazole |
40 |
Phase IIB Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Safety and Efficacy of Topical Difluoromethylornithine (DFMO) With and Without a Topical Corticosteroid Cream (Triamcinolone 0.1%) in the Therapy of Actinic Keratoses (AK) on the Forearms |
Completed |
NCT00021294 |
Phase 2 |
eflornithine;triamcinolone |
41 |
A Phase II Trial of SU5416 (NSC #696819) in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck |
Completed |
NCT00006361 |
Phase 2 |
semaxanib |
42 |
A Phase 2 Study of Dasatinib in Patients With Transplant and Non-Transplant Related Unresectable or Metastatic Cutaneous Squamous Cell Carcinoma and RAI Stage 0-1 Chronic Lymphocytic Leukemia |
Completed |
NCT00563290 |
Phase 2 |
dasatinib |
43 |
A Phase IIb Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topical Bacteriophage T4 Endonuclease V in Renal Allograft Recipients With a History of Non-melanoma Skin Cancer |
Completed |
NCT00089180 |
Phase 2 |
liposomal T4N5 lotion |
44 |
A Phase II Trial of 4-5 Hour and 18-24 Hour Applications of 20% Topical ALA for Photodynamic Therapy of Cutaneous Carcinomas and Actinic Keratoses |
Completed |
NCT00002975 |
Phase 2 |
aminolevulinic acid |
45 |
ALPHA INTERFERON AND CIS-RETINOIC ACID FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS |
Completed |
NCT00002506 |
Phase 2 |
isotretinoin |
46 |
Phase II Study of Metastatic Melanoma Using a Chemoradiation Lymphodepleting Conditioning Regimen Followed by Infusion of Anti-Mart-1 and Anti-gp100 TCR-Gene Engineered Lymphocytes and Peptide Vaccines |
Completed |
NCT00923195 |
Phase 2 |
MART-1: 26-35(27L) Peptide;Montanide ISA 51 VG;gp100:154-162 Peptide;Aldesleukin;Fludarabine;Cyclophosphamide |
47 |
A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Celecoxib in Subjects With Basal Cell Nevus Syndrome |
Completed |
NCT00023621 |
Phase 2 |
celecoxib |
48 |
Phase II Evaluation of Peptide Immunization and LMB-2 in Metastatic Melanoma |
Completed |
NCT00295958 |
Phase 2 |
|
49 |
Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma |
Completed |
NCT00885534 |
Phase 2 |
Cisplatin, Vinblastine, Temozolomide |
50 |
A Phase II Study of ZD1839 and Radiation in Patients With Squamous Cell Carcinoma of the Skin |
Completed |
NCT00126555 |
Phase 2 |
Gefitinib |
|